Gujarat Themis Biosyn Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 7.26 Cr
as on 28-06-2024
- Company Age 43 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.98 Cr
as on 28-06-2024
- Satisfied Charges ₹ 41.61 Cr
as on 28-06-2024
- Revenue 30.35%
(FY 2023)
- Profit 32.88%
(FY 2023)
- Ebitda 27.86%
(FY 2023)
- Net Worth 44.35%
(FY 2023)
- Total Assets 35.78%
(FY 2023)
About Gujarat Themis Biosyn
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506879.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 7.26 Cr.
The company currently has active open charges totaling ₹7.98 Cr. The company has closed loans amounting to ₹41.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gujarat Themis Biosyn Ltd India are Rahul Soni as Company Secretary, Mr Guhathakurata as Ceo, and Mr Desai as Cfo. Vikram Sanghvi, Siddharth Kusumgar, Kirandeep Madan, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24230GJ1981PLC004878
- Company No.
004878
- Stock Symbol
BSE : 506879
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1981
- Date of AGM
09 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gujarat Themis Biosyn?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Soni | Company Secretary | 12-May-2021 | Current |
| Mr Guhathakurata | CEO | 05-Jan-2023 | Current |
Mr Desai  | CFO | 17-Mar-2015 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Kusumgar | Director | 28-May-2015 | Current |
| Kirandeep Madan | Director | 01-May-2021 | Current |
| Vikram Sanghvi | Director | 25-Mar-2015 | Current |
| Vijay Agarwal | Director | 31-Mar-2006 | Current |
| Sachin Dinesh | Director | 25-Oct-2008 | Current |
| Dinesh Patel | Director | 25-May-1992 | Current |
Financial Performance and Corporate Structure Insights of Gujarat Themis Biosyn.
Gujarat Themis Biosyn Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 30.35% increase. The company also saw a substantial improvement in profitability, with a 32.88% increase in profit. The company's net worth Soared by an impressive increase of 44.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gujarat Themis Biosyn?
In 2023, Gujarat Themis Biosyn had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Engineered Coated Fabric Private LimitedActive 39 years 6 monthsSiddharth Kusumgar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Vysya Bank Ltd. Creation Date: 19 Oct 2000 | ₹7.50 M | Open |
Others Creation Date: 15 May 2000 | ₹7.23 Cr | Open |
Union Bank Of India Creation Date: 11 Apr 2008 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Gujarat Themis Biosyn?
Gujarat Themis Biosyn has a workforce of 354 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujarat Themis Biosyn, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujarat Themis Biosyn's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
